No Prescription |
 |
 | ||
|
LEDERMYCIN Declomycin |
|
| ||
No Prescription » Prescription Drugs 10 » LEDERMYCIN Declomycin Demeclocycline is used to treat bacterial infections including pneumonia and other respiratory tract infections; acne; and infections of skin genital and urinary systems. Demeclocycline is in a class of medications called tetracycline antibiotics. It works by preventing the growth and spread of bacteria. Antibiotics will not work for colds flu or other viral infections.Demeclocycline comes as a tablet to take by mouth. It usually is taken two to four times a day. Drink a full glass of water with each dose. Take demeclocycline on an empty stomach at least 1 hour before or 2 hours after meals. Do not take demeclocycline with food especially dairy products such as milk yogurt cheese and ice cream. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take demeclocycline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Buy LEDERMYCIN Declomycin and other Prescription Drugs 10 products online at Medstore. 780
About LEDERMYCIN Declomycin: Product Type: Prescription Drugs 10 LEDERMYCIN ( Declomycin Generic Demeclocycline ) LEDERMYCIN (Declomycin Generic Demeclocycline) Declomycin Generic Demeclocycline 150mg Caps 10 Declomycin Generic Demeclocycline LEDERMYCIN
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
